Yufei Lan

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Evidence from European ancestry genome-wide association studies and a case-control study suggests several selenoproteins are linked to a decreased risk of Alzheimer's disease.

Evidence from European ancestry genome-wide association studies and a case-control study suggests several selenoproteins are linked to a decreased risk of Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD

Published: August 13, 2026

A Cascaded DNA Nanocircuit for Multi-Signal-Responsive Precision siRNA Delivery in Cancer Therapy.

A Cascaded DNA Nanocircuit for Multi-Signal-Responsive Precision siRNA Delivery in Cancer Therapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 16, 2026

Integrative Multi-Omics Analysis Reveals the Characteristic Metabolic Signature of Glioma and Enables Plasma-Based Liquid Biopsy.

Integrative Multi-Omics Analysis Reveals the Characteristic Metabolic Signature of Glioma and Enables Plasma-Based Liquid Biopsy.

Journal: Research (Washington, D.C.)

Published: January 06, 2026

Lock-equipped six-helix DNA bundle-mediated siSTING delivery ameliorates Alzheimer's disease via cGAS-STING inhibition.

Lock-equipped six-helix DNA bundle-mediated siSTING delivery ameliorates Alzheimer's disease via cGAS-STING inhibition.

Journal: Journal of nanobiotechnology

Published: December 02, 2025

STAR Therapy: Spatiotemporal Antitumor Regimen via a Size-Gated DNA Hydrogel Drug Delivery System.

STAR Therapy: Spatiotemporal Antitumor Regimen via a Size-Gated DNA Hydrogel Drug Delivery System.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: September 06, 2025

Isovalerylspiramycin I Reprograms the Immunosuppressive and Temozolomide-Resistant Microenvironment by Inhibiting the Frizzled-5/Wnt/β-Catenin Pathway in Glioblastoma.

Isovalerylspiramycin I Reprograms the Immunosuppressive and Temozolomide-Resistant Microenvironment by Inhibiting the Frizzled-5/Wnt/β-Catenin Pathway in Glioblastoma.

Journal: Research (Washington, D.C.)

Published: April 22, 2025

Spatially selective clearance of inflammation-mediated reactive oxygen species in injured kidney cells.

Spatially selective clearance of inflammation-mediated reactive oxygen species in injured kidney cells.

Journal: Theranostics

Published: February 26, 2025

Bidirectional regulation of reactive oxygen species for radiosensitization in nasopharyngeal carcinoma.

Bidirectional regulation of reactive oxygen species for radiosensitization in nasopharyngeal carcinoma.

Journal: Journal of nanobiotechnology

Published: October 27, 2024

Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma.

Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma.

Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy

Published: May 31, 2024

IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma.

IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma.

Journal: Journal of translational medicine

Published: April 04, 2024

Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention.

Histone H3K9 Lactylation Confers Temozolomide Resistance in Glioblastoma via LUC7L2-Mediated MLH1 Intron Retention.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: November 30, 2023

IRP1 mediated ferroptosis reverses temozolomide resistance in glioblastoma via affecting LCN2/FPN1 signaling axis depended on NFKB2.

IRP1 mediated ferroptosis reverses temozolomide resistance in glioblastoma via affecting LCN2/FPN1 signaling axis depended on NFKB2.

Journal: iScience

Published: February 06, 2023

Showing 1-12 of 13

Last Updated: 09/26/2026